Poster Abstract Session:
68. Resistance Mechanisms: Gram-Positive
Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Investigative ID


Presentations:
710
Increased Clinical Failure Rates Associated with Reduced Metronidazole Susceptibility in Clostridioides difficile
Anne Gonzales-Luna, PharmD; Wan-Jou Shen, MS; Kierra Dotson, PharmD, BCPS; Chris Lancaster, MS; Bradley Endres, PhD; Feroz Hossain, MD; Khurshida Begum, PhD; Patricia Cernoch, RM; Katherine Perez, PharmD, BCPS-AQ ID; Naradah Tisdel, MT; Miriam Barrett, RM; Kenneth L. Muldrew, MD, MPH; M. Jahangir Alam, PhD; Kevin Garey, PharmD, MS; Julian Hurdle, PhD
Posters
  • gonzalesluna_mtzresistance_idweek.pdf (1.0 MB)
    • 711
    Molecular Epidemiology of Daptomycin Non-Susceptibility in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
    Ayesha Sundaram, BS; Mary Beth Perri, MT; Katherine Gurdziel, PhD; Hind Hadid, MD; Erica Herc, MD; Marcus J Zervos, MD
    Posters
  • IDweek_Sundaram.pdf (1.4 MB)
    • 712
    Identification of a novel tedizolid resistance mutation in rpoB of methicillin-resistant Staphylococcus aureus
    Brian Werth, PharmD; Kelsi Penewit, MS; Stephen Salipante, MD, PhD; Tianwei Shen, MS; Libin Xu, PhD; Abhinav Nath, PhD
    Posters
  • IDWEEK_2018_poster.pdf (1.7 MB)
    • 713
    Vancomycin Heteroresistance in Coagulase Negative Staphylococci (CoNS) Causing Central Line Associated Bloodstream Infection (CLABSI) in Pediatric Patients With Leukemia
    Tina Dao, BS; Joshua Parsons, PhD; Randall Hayden, MD; Jeffrey Rubnitz, MD PhD; Joshua Wolf, MBBS FRACP; Jason Rosch, PhD
    Posters
  • 2nd proof 9-26-18 ID conference 2018 JW edits_FINAL.pdf (5.1 MB)

    • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.